August 30, 2015 | The Israel-based venture capital firm and incubator Trendlines Group has opened a branch in Singapore. Trendlines hopes to help Singaporean medical technology companies develop their product for commercialization in larger markets, like the United States and China. In addition, there are reports that Trendlines Group is interested in issuing an initial public offering on a Singapore Exchange in November, which would value the company at between $80-$100 million. Trendlines Group was founded in 2007 and has about 50 startups in its portfolio of medical and agricultural technology companies.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments